Lake Street analyst Brooks O’Neil maintained a Buy rating on Augmedix (AUGX – Research Report) today and set a price target of $8.00. The company’s shares closed yesterday at $4.53.
According to TipRanks, O’Neil is an analyst with an average return of -3.6% and a 38.33% success rate. O’Neil covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, Avita Medical, and Accuray.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Augmedix with a $7.13 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Based on Augmedix’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $10.78 million and a GAAP net loss of $5.03 million. In comparison, last year the company earned a revenue of $7.33 million and had a GAAP net loss of $7.34 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Augmedix (AUGX) Company Description:
Augmedix Inc humanizes the clinician-patient experience by enabling clinicians to focus on what matters most, delivering high-quality patient care. It converts natural clinician-patient conversation into medical documentation and provides real-time administrative support, including referrals, orders, and reminders. The service, which supports over 35 specialties, delivers timely, accurate and comprehensive medical documentation to several of the healthcare systems in the U.S. and to hundreds of independent clinicians nationwide. Augmedix focuses on saving clinicians 2-3 hours per day, improve clinician productivity by as much as 20%, and increase clinicians’ satisfaction with work-life balance over 40%.
Read More on AUGX:
- Augmedix price target raised to $8 from $6 at Lake Street
- Augmedix and Ellipsis Health partnering in automated mental health screenings
- Augmedix announces partnerships with Myndshft, Ellipsis, Sullivan Group
- Augmedix announces Augmedix Go, an AI medical documentation product
- Augmedix Announces New AI Medical Documentation Product, Augmedix Go, a Clinician-Controlled Mobile App
